| __timestamp | Takeda Pharmaceutical Company Limited | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 2395000 |
| Thursday, January 1, 2015 | 535405000000 | 9057000 |
| Friday, January 1, 2016 | 558755000000 | 393000 |
| Sunday, January 1, 2017 | 495921000000 | 79309000 |
| Monday, January 1, 2018 | 659690000000 | 134428000 |
| Tuesday, January 1, 2019 | 1089764000000 | 175431000 |
| Wednesday, January 1, 2020 | 994308000000 | 124165000 |
| Friday, January 1, 2021 | 1106846000000 | 121875000 |
| Saturday, January 1, 2022 | 1244072000000 | 10114000 |
| Sunday, January 1, 2023 | 1431505000000 | 9206000 |
| Monday, January 1, 2024 | 1431505000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. Takeda Pharmaceutical Company Limited, a global leader, and Wave Life Sciences Ltd., a burgeoning biotech firm, offer a fascinating contrast in cost of revenue trends from 2014 to 2023.
Takeda's cost of revenue has shown a robust upward trajectory, growing by approximately 175% over the decade. This reflects its expansive operations and strategic acquisitions, notably peaking in 2023 with a 15% increase from the previous year.
Conversely, Wave Life Sciences exhibits a more volatile pattern, with costs fluctuating significantly. The peak in 2019 was followed by a sharp decline, highlighting the challenges faced by smaller biotech firms in scaling operations.
This comparative analysis underscores the diverse financial strategies and market pressures faced by pharmaceutical giants and emerging biotech companies alike.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Mesoblast Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Incyte Corporation and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Wave Life Sciences Ltd.'s Expenses
Cost of Revenue Comparison: ACADIA Pharmaceuticals Inc. vs Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Xencor, Inc.
Cost of Revenue: Key Insights for Wave Life Sciences Ltd. and Viridian Therapeutics, Inc.